Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

Year in Review: Endovascular Saw Paclitaxel Storm Rage, CLI Care Advance in 2019

News Features

Year in Review: Endovascular Saw Paclitaxel Storm Rage, CLI Care Advance in 2019

December 12, 2019

LEVANT: Patient-Level Data Show No Increase in 5-Year Death for Paclitaxel DCBs in PAD

News Conference News TCT 2019

LEVANT: Patient-Level Data Show No Increase in 5-Year Death for Paclitaxel DCBs in PAD

September 28, 2019

AHA Outlines Diagnosis, Treatment Options for Underrecognized Critical Limb Ischemia

News Daily News

AHA Outlines Diagnosis, Treatment Options for Underrecognized Critical Limb Ischemia

August 12, 2019

News Industry News

Boston Scientific Responds to the FDA’s Guidance on Use of Peripheral Paclitaxel Devices for Treatment of PAD

August 07, 2019

TCTMD’s Top 10 Most Popular Stories for June 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for June 2019

June 28, 2019

US Data Convey the Scope of Bleeding in Lower-Extremity Peripheral Interventions

News Daily News

US Data Convey the Scope of Bleeding in Lower-Extremity Peripheral Interventions

June 18, 2019

Peripheral Vision: As Office-Based Practices Proliferate, Who Is Watching Out for Patients?

News Features

Peripheral Vision: As Office-Based Practices Proliferate, Who Is Watching Out for Patients?

May 01, 2019

IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease

News Daily News

IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease

January 25, 2019

Industry, Investigators Push Back With Patient-Level Data Showing No Increased Death From Paclitaxel-Based PAD Therapies

News Daily News

Industry, Investigators Push Back With Patient-Level Data Showing No Increased Death From Paclitaxel-Based PAD Therapies

January 23, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.